TABLE 2.
Results of the serological follow-up of the patient with HIV infection and a negative rapid Determine HIV 1/2 test
| Assaya | Result at follow-up time ofb:
|
|||
|---|---|---|---|---|
| Day 0 | 10 days | 3 mo | 14 mo | |
| Blot | ||||
| gp120 | − | − | − | − |
| gp41 | 2+ | 2+ | +/− | 2+ |
| p31 | 1+ | 1+ | − | − |
| p24 | − | − | 1+ | +/− |
| p17 | − | − | − | − |
| gp105 | − | − | − | − |
| gp36 | − | − | − | − |
| Conclusion | +/− | +/− | +/− | +/− |
| Rapid test | − | Weakly + | Weakly + | + |
| MEIA | 12.7 | |||
a
Rapid test, Determine 1/2 HIV rapid test; Blot, line immunoblot assay.
b
−, negative; +, positive; +/−, indeterminate. Day 0 was the day of admission. At 18 days, highly active antiretroviral treatment was started. At 3 months, the HIV RNA load was 538 copies per ml, and the CD4 cell count was 0.450 × 10−9/liter.